01—History
Cost of Revenue History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $868.0M
1 older move runs past ±150% (largest +32612.5%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is Moderna, Inc.'s current cost of revenue?
Moderna, Inc. (MRNA) annual cost of revenue for 2025 was $868.0M, a 40.71% decline from 2024. Moderna, Inc. cost of revenue for the quarter ending March 31, 2026 was $955.0M.
What was Moderna, Inc.'s cost of revenue in 2024?
Moderna, Inc. annual cost of revenue for 2024 was $1.46B, a 68.80% decline from 2023.
What was Moderna, Inc.'s cost of revenue in 2023?
Moderna, Inc. annual cost of revenue for 2023 was $4.69B, a 13.35% decline from 2022.
What is Moderna, Inc.'s 5-year cost of revenue CAGR?
Moderna, Inc. cost of revenue grew at a compound annual growth rate (CAGR) of 155.32% from FY2020 to FY2025, going from $8.0M to $868.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)